コグナイト ソフトウェアに関するコメント

$コグナイト ソフトウェア(CGNT.US)$ chart pattern looks good, bought some here to test where these goes after 1 month 📈

$テスラ(TSLA.US)$ — Shares fell 1.2% after U.S. safety regulators said Tesla will recall more than 2 million vehicles to fix issues with its driver assistance system. The electric vehicle maker will send out a software update to fix the problem, which impacts models Y, S, 3 and X produced between Oct. 5, 2012 and Dec. 7, 2023.
$ファイザー(PFE.US)$ — The biopharmaceutical stock dropped 7.4% after Pfizer issued full-year guidance for adjusted earnings ...

Gapping up
$ターゲット(TGT.US)$ +1.14% (Target announced it would increase its dividend by 1.9%, or 2 cents, to $1.10 per share.)
$アルデイラ セラピューティクス(ALDX.US)$ +7.89% (Aldeyra announced it say statistical significance in the primary and all secondary endpoints for a drug that could be used for a type of eye inflammation.)
$ドミノ ピザ(DPZ.US)$ +2.31% (The pizza chain rose 2.3% following an upgrade to buy from hold by Stifel. The firm ...

$コグナイト ソフトウェア(CGNT.US)$ watch this

Technology stocks were advancing on Wednesday, with the SPDR Technology Select Sector ETF $テクノロジー・セレクト・セクター SPDR ファンド(XLK.US)$ rising 0.5% while the Philadelphia Semiconductor Index was gaining 0.7% this afternoon.
In company news, Cognyte Software $コグナイト ソフトウェア(CGNT.US)$ rose almost 14% after the investigative analytics software firm Wednesday reported a non-GAAP loss of $0.04 per share in Q2, reversing a $0.17 per share adjusted p...

Gapping up
In reaction to earnings/guidance:
• $ソーア・インダストリーズ(THO.US)$ +2.5%
Other news:
• $アキュメン ファーマシューティカルズ(ABOS.US)$+76.8% (in response with BIIB)
• $バイオジェン(BIIB.US)$ +45.6% (reports Lecanemab confirmatory Phase 3 Clarity AD study met primary endpoint)
• $ナノックス・イメージング(NNOX.US)$+22.8% (submitted a 510(k) premarket notification to the FDA on Sept 26 for its multi­source 3D digital tomosynthesis system)
• $オキュジェン(OCGN.US)$ +9.3% (en...

Upgrades
• $ケイデンス デザイン システムズ(CDNS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $175 (from $160)
• $フェデレーテッド エルメス B(FHI.US)$ : KBW Upgrades to Outperform from Market Perform - PT $540
• $ゴールドマン サックス グループ(GS.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $380 (from $360)
• $マクドナルド(MCD.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $278 (from $245)
• $オラクル(ORCL.US)$ : Exane Upg...

Gainers:
• $ケザー ライフ サイエンシズ(KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $ストゥロ バイオファーマ(STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $セラゴン ネットワークス(CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $トリップ・ドット・コム・グループ(TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $アピックス メディカル(APYX.US)$ +8% (anno...

Gainers:
• $アーカス バイオサイエンシズ(RCUS.US)$ +11.2% (appointed to join S&P SmallCap 600)
• $スフィア3D(ANY.US)$ +10.13% (mutually agreed to terminate merger agreement with Gryphon Digital Mining)
• $セラバンス バイオファーマ(TBPH.US)$ +3.05% (announced results from Study 0170)
• $カーニバル(CUK.US)$ +4.7% (reported that March 28-April 3 was the busiest booking week in company history)
• $キャッスル バイオサイエンシズ(CSTL.US)$ +4.4% (agreed to acquire Althe...